spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 3


Fig. 3. ML-9 dose-dependently inhibits SOCE and Icrac. (A) Relative intracellular Ca2+ concentrations were monitored in wild-type HEK293 cells treated with 100 µM ML-9 (red trace) or left untreated (black trace). Ca2+ stores were depleted with 2 µM thapsigargin in nominally Ca2+-free extracellular medium, and extracellular Ca2+ was restored to 1.8 mM 15 minutes later to reveal SOCE. ML-9 was removed at the end of the experiment to demonstrate the reversibility of ML-9 inhibition. Each trace represents the averaged response of all cells measured on a single coverslip. (B) The average peak SOCE responses above baseline from experiments performed as described in panel A were averaged for untreated control cells (n=150; five coverslips) or cells treated with 1 µM (n=78; three coverslips), 10 µM (n=76; three coverslips), 50 µM (n=84; three coverslips) or 100 µM (n=64; three coverslips) ML-9. Data are reported as the percentage of untreated control±s.e.m.; *, significant difference compared with control (P<0.001) based on one-way ANOVA. (C) Experiments were performed as described in panel A, but ML-9 was added 5 minutes following restoration of extracellular Ca2+ (red trace). (D) For experiments performed as described in panel C, the baseline-subtracted 340/380 ratio 5 minutes following ML-9 addition was divided by that just before addition. Data are reported as the percentage of untreated control±s.e.m. for untreated controls (n=151; five coverslips), and for 1 µM (n=90; four coverslips), 10 µM (n=80, three coverslips), 50 µM (n=61, three coverslips) and 100 µM (n=74, three coverslips) ML-9; *, significant difference compared with control (P<0.001) based on one-way ANOVA. (E) Whole-cell patch clamp analysis was performed with a pipette solution containing 20 mM BAPTA and 25 µM Ins(1,4,5)P3 to deplete intracellular Ca2+ stores. The cell was initially perfused with an extracellular solution containing 10 mM Ca2+. At the time indicated, perfusion was switched to a divalent-free (DVF) solution, which resulted in the development of a Na+ current. Perfusion was then returned to 10 mM Ca2+, and 100 µM ML-9 was added at the time indicated. Note the decrease in the Ca2+ current upon ML-9 addition. In the continued presence of ML-9, perfusion was again switched to DVF solution. At the end of the experiment, 10 mM extracellular Ca2+ was restored and ML-9 was removed to demonstrate reversal of inhibition of the Ca2+ current. (F) For experiments performed as described in panel E, the peak Na+ currents at the initial switch to DVF solution in the absence of ML-9 (control) and that at the second switch to DVF in the presence of 100 µM ML-9 were averaged and are expressed as mean±s.e.m. (n=6); *, significant difference compared with control (P<0.005) based on Student's t test.





Right arrow Return to article